USD 0.0
(-90.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | - USD | 100.0% |
2022 | -112.3 Thousand USD | 30.37% |
2021 | -161.29 Thousand USD | -277.18% |
2020 | 91.03 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2014 | 4083.00 USD | 0.0% |
2013 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 FY | - USD | 100.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 100.0% |
2022 Q2 | -2090.00 USD | -2588.1% |
2022 Q1 | 84.00 USD | 100.07% |
2022 FY | -112.3 Thousand USD | 30.37% |
2022 Q4 | -93 Thousand USD | -248.56% |
2022 Q3 | -26.68 Thousand USD | -1176.6% |
2021 FY | -161.29 Thousand USD | -277.18% |
2021 Q3 | -52.08 Thousand USD | -1260.69% |
2021 Q4 | -118.54 Thousand USD | -127.63% |
2021 Q2 | 4487.00 USD | -7.31% |
2021 Q1 | 4841.00 USD | -94.68% |
2020 FY | 91.03 Thousand USD | 0.0% |
2020 Q4 | 91.03 Thousand USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q1 | 1575.00 USD | 0.0% |
2014 Q4 | - USD | -100.0% |
2014 Q3 | 386.00 USD | -81.81% |
2014 Q2 | 2122.00 USD | 34.73% |
2014 FY | 4083.00 USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Bio Medica Corporation | -193 Thousand USD | 100.0% |
Arrayit Corporation | 2.57 Million USD | 100.0% |
Atlantic International Corp. | -154.23 Thousand USD | 100.0% |
Biocept, Inc. | -2.58 Million USD | 100.0% |
Bioqual, Inc. | 7.42 Million USD | 100.0% |
CardioGenics Holdings Inc | - USD | NaN% |
DermTech, Inc. | 276 Thousand USD | 100.0% |
Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 100.0% |
HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 100.0% |
iMD Companies, Inc. | -23.63 Thousand USD | 100.0% |
IDenta Corp. | 662.97 Thousand USD | 100.0% |
Interpace Biosciences, Inc. | 23.04 Million USD | 100.0% |
Integrative Health Technologies, Inc. | 77.57 Thousand USD | 100.0% |
InVitro International | 635.98 Thousand USD | 100.0% |
Lumos Diagnostics Holdings Limited | 6.56 Million USD | 100.0% |
Many Bright Ideas Technologies Inc. | - USD | NaN% |
Medical Imaging Corp. | 1.09 Million USD | 100.0% |
NovelStem International Corp. | 12 Thousand USD | 100.0% |
Optigenex Inc. | -102.96 Thousand USD | 100.0% |
PharmChem, Inc. | 3.9 Million USD | 100.0% |
Proteome Sciences plc | 2.09 Million USD | 100.0% |
Response Genetics, Inc | 3.94 Million USD | 100.0% |
Rennova Health, Inc. | 6.26 Million USD | 100.0% |
RushNet, Inc. | 1.1 Million USD | 100.0% |
ScreenPro Security Inc. | 856.57 Thousand USD | 100.0% |
Stella Diagnostics Inc. | - USD | NaN% |
StageZero Life Sciences Ltd. | -403.74 Thousand USD | 100.0% |
Todos Medical Ltd. | 4.31 Million USD | 100.0% |